Literature DB >> 28758140

Endogenous C-terminal Tagging by CRISPR/Cas9 in Trypanosoma cruzi.

Noelia Lander1, Miguel A Chiurillo1, Aníbal E Vercesi1, Roberto Docampo1,2.   

Abstract

To achieve the C-terminal tagging of endogenous proteins in T. cruzi we use the Cas9/pTREX-n vector (Lander et al., 2015) to insert a specific tag sequence (3xHA or 3xc-Myc) at the 3' end of a specific gene of interest (GOI). Chimeric sgRNA targeting the 3' end of the GOI is PCR-amplified and cloned into Cas9/pTREX-n vector. Then a DNA donor molecule to induce DNA repair by homologous recombination is amplified. This donor sequence contains the tag sequence and a marker for antibiotic resistance, plus 100 bp homology arms corresponding to regions located right upstream of the stop codon and downstream of the Cas9 target site at the GOI locus. Vectors pMOTag23M (Oberholzer et al., 2006) or pMOHX1Tag4H (Lander et al., 2016b) are used as PCR templates for DNA donor amplification. Epimastigotes co-transfected with the sgRNA/Cas9/pTREX-n construct and the DNA donor cassette are then cultured for 5 weeks with antibiotics for selection of double resistant parasites. Endogenous gene tagging is finally verified by PCR and Western blot analysis.

Entities:  

Keywords:  CRISPR/Cas9; Endogenous tagging; Genome editing; Subcellular localization; Trypanosoma cruzi

Year:  2017        PMID: 28758140      PMCID: PMC5531189          DOI: 10.21769/BioProtoc.2299

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  12 in total

Review 1.  Specific chemotherapy of Chagas disease: controversies and advances.

Authors:  Julio A Urbina; Roberto Docampo
Journal:  Trends Parasitol       Date:  2003-11

2.  Isotopes incorporated in the nucleic acids of Trypanosoma mega.

Authors:  G J BONE; M STEINERT
Journal:  Nature       Date:  1956-08-11       Impact factor: 49.962

3.  A vector series for rapid PCR-mediated C-terminal in situ tagging of Trypanosoma brucei genes.

Authors:  Michael Oberholzer; Sabine Morand; Stefan Kunz; Thomas Seebeck
Journal:  Mol Biochem Parasitol       Date:  2005-09-29       Impact factor: 1.759

4.  Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector.

Authors:  M P Vazquez; M J Levin
Journal:  Gene       Date:  1999-11-01       Impact factor: 3.688

5.  Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure.

Authors:  E Medina-Acosta; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1993-06       Impact factor: 1.759

6.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI.

Authors:  B Zingales; S G Andrade; M R S Briones; D A Campbell; E Chiari; O Fernandes; F Guhl; E Lages-Silva; A M Macedo; C R Machado; M A Miles; A J Romanha; N R Sturm; M Tibayrenc; A G Schijman
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-11       Impact factor: 2.743

Review 7.  Molecular parasitology in the 21st century.

Authors:  Roberto Docampo
Journal:  Essays Biochem       Date:  2011       Impact factor: 8.000

Review 8.  Genome Editing by CRISPR/Cas9: A Game Change in the Genetic Manipulation of Protists.

Authors:  Noelia Lander; Miguel A Chiurillo; Roberto Docampo
Journal:  J Eukaryot Microbiol       Date:  2016-07-15       Impact factor: 3.346

9.  CRISPR/Cas9-Induced Disruption of Paraflagellar Rod Protein 1 and 2 Genes in Trypanosoma cruzi Reveals Their Role in Flagellar Attachment.

Authors:  Noelia Lander; Zhu-Hong Li; Sayantanee Niyogi; Roberto Docampo
Journal:  MBio       Date:  2015-07-21       Impact factor: 7.867

10.  CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi.

Authors:  Duo Peng; Samarchith P Kurup; Phil Y Yao; Todd A Minning; Rick L Tarleton
Journal:  MBio       Date:  2014-12-30       Impact factor: 7.867

View more
  12 in total

1.  Calcium-sensitive pyruvate dehydrogenase phosphatase is required for energy metabolism, growth, differentiation, and infectivity of Trypanosoma cruzi.

Authors:  Noelia Lander; Miguel A Chiurillo; Mayara S Bertolini; Melissa Storey; Anibal E Vercesi; Roberto Docampo
Journal:  J Biol Chem       Date:  2018-09-19       Impact factor: 5.157

Review 2.  CRISPR-Cas Biology and Its Application to Infectious Diseases.

Authors:  Jeffrey R Strich; Daniel S Chertow
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 3.  State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.

Authors:  Noelia Lander; Miguel A Chiurillo
Journal:  J Eukaryot Microbiol       Date:  2019-07-07       Impact factor: 3.346

4.  Gene Disruption of Honey Bee Trypanosomatid Parasite, Lotmaria passim, by CRISPR/Cas9 System.

Authors:  Qiushi Liu; Jing Lei; Tatsuhiko Kadowaki
Journal:  Front Cell Infect Microbiol       Date:  2019-04-26       Impact factor: 5.293

5.  Overexpression of Trypanosoma cruzi High Mobility Group B protein (TcHMGB) alters the nuclear structure, impairs cytokinesis and reduces the parasite infectivity.

Authors:  Luis Emilio Tavernelli; Maria Cristina M Motta; Camila Silva Gonçalves; Marcelo Santos da Silva; Maria Carolina Elias; Victoria Lucia Alonso; Esteban Serra; Pamela Cribb
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

6.  Mitochondrial Pyruvate Carrier Subunits Are Essential for Pyruvate-Driven Respiration, Infectivity, and Intracellular Replication of Trypanosoma cruzi.

Authors:  Raquel S Negreiros; Noelia Lander; Miguel A Chiurillo; Anibal E Vercesi; Roberto Docampo
Journal:  mBio       Date:  2021-04-06       Impact factor: 7.867

7.  Drug Target Validation of the Protein Kinase AEK1, Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi.

Authors:  Miguel A Chiurillo; Bryan C Jensen; Roberto Docampo
Journal:  Microbiol Spectr       Date:  2021-09-29

8.  Utilization of proliferable extracellular amastigotes for transient gene expression, drug sensitivity assay, and CRISPR/Cas9-mediated gene knockout in Trypanosoma cruzi.

Authors:  Yuko Takagi; Yukie Akutsu; Motomichi Doi; Koji Furukawa
Journal:  PLoS Negl Trop Dis       Date:  2019-01-14

Review 9.  Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.

Authors:  Juan Felipe Osorio-Méndez; Ana María Cevallos
Journal:  Front Cell Infect Microbiol       Date:  2019-01-07       Impact factor: 5.293

10.  A CRISPR/Cas9-riboswitch-Based Method for Downregulation of Gene Expression in Trypanosoma cruzi.

Authors:  Noelia Lander; Teresa Cruz-Bustos; Roberto Docampo
Journal:  Front Cell Infect Microbiol       Date:  2020-02-27       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.